Cargando…
In silico analysis of hypoxia activated prodrugs in combination with anti angiogenic therapy through nanocell delivery
Tumour hypoxia is a well-studied phenomenon with implications in cancer progression, treatment resistance, and patient survival. While a clear adverse prognosticator, hypoxia is also a theoretically ideal target for guided drug delivery. This idea has lead to the development of hypoxia-activated pro...
Autores principales: | Meaney, Cameron, Rhebergen, Sander, Kohandel, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282674/ https://www.ncbi.nlm.nih.gov/pubmed/32463836 http://dx.doi.org/10.1371/journal.pcbi.1007926 |
Ejemplares similares
-
Combining hypoxia-activated prodrugs and radiotherapy in silico: Impact of treatment scheduling and the intra-tumoural oxygen landscape
por: Hamis, Sara, et al.
Publicado: (2020) -
Nanocell targeting using engineered bispecific antibodies
por: Taylor, Karin, et al.
Publicado: (2014) -
Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma
por: Khan, Muhammad Babar, et al.
Publicado: (2021) -
Computational Multi-Scale Modeling of Drug Delivery into an Anti-Angiogenic Therapy-Treated Tumor
por: Mohammadi, Mahya, et al.
Publicado: (2023) -
Self-assembly of Deinococcus radiodurans supports nanocell scenario of life origin
por: Bernadotte, Alexandra, et al.
Publicado: (2017)